Analyst Activity – HC Wainwright Initiates Coverage On Diffusion Pharmaceuticals (NASDAQ:DFFN) With a Buy

Analyst Ratings For Diffusion Pharmaceuticals (NASDAQ:DFFN)

Story continues below

Today, HC Wainwright initiated coverage on Diffusion Pharmaceuticals (NASDAQ:DFFN) with a Buy with a price target of $1.25.

Some recent analyst ratings include

  • 3/21/2018-HC Wainwright initiated coverage with a Buy rating.


    Recent Trading Activity for Diffusion Pharmaceuticals (NASDAQ:DFFN)
    Shares of Diffusion Pharmaceuticals closed the previous trading session at with 0.0 shares trading hands.

    An ad to help with our costs